Metabolite

KNApSAcK Entry

id C00003221
Name (-)-Artemisin / 8-Hydroxysantonin / [3S-(3alpha,3aalpha,4alpha,5abeta,9bbeta)]-3a,5,5a,9b-Tetrahydro-4-hydroxy-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8(3H,4H)-dione
CAS RN 481-05-0
Standard InChI InChI=1S/C15H18O4/c1-7-9(16)4-5-15(3)6-10(17)11-8(2)14(18)19-13(11)12(7)15/h4-5,8,10-11,13,17H,6H2,1-3H3/t8-,10-,11+,13-,15+/m0/s1
Standard InChI (Main Layer) InChI=1S/C15H18O4/c1-7-9(16)4-5-15(3)6-10(17)11-8(2)14(18)19-13(11)12(7)15/h4-5,8,10-11,13,17H,6H2,1-3H3

Cluster

Phytochemical cluster No. 38
KCF-S cluster No. 2117

Link

ChEMBL

By standard InChI CHEMBL158124
By standard InChI Main Layer CHEMBL158124 CHEMBL1673435

KEGG

By LinkDB C09344

CTD

By CAS RN C075875

Human Protein / Gene in interaction

1 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
Q12809 Potassium voltage-gated channel subfamily H member 2 KCNH, Kv10-12.x (Ether-a-go-go) CHEMBL1673435 CHEMBL1676103 (1)
2 / 2

CTD interaction (1)

compound gene gene name gene description interaction interaction type form reference
pmid
C075875 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) artemisin results in decreased activity of CYP1A2 protein decreases activity
protein 16261361

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (2)

OMIM preferred title UniProt
#613688 Long qt syndrome 2; lqt2 Q12809
#609620 Short qt syndrome 1; sqt1 Q12809

KEGG DISEASE (2)

KEGG disease name UniProt
H00720 Long QT syndrome Q12809 (related)
H00725 Short QT syndrome Q12809 (related)